BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2019 and 2022 by a US stock, returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2019-2022	2,780,387.8%
LMF Acquisition Opportunities (ICU)	2019-2022	2,614,695.92%
Next Technology (NXTT)	2019-2022	1,162,346.87%
GeoVax Labs (GOVX)	2019-2022	590,525%
Connexa Sports Technologies (YYAI)	2019-2022	467,900%
MDxHealth SA ADR (MDXH)	2019-2022	388,723.53%
Heart Test Laboratories Inc Common Stock (HSCS)	2019-2022	246,958.82%
Integra Resources (ITRG)	2019-2022	158,150%
Guardforce AI (GFAI)	2019-2022	24,323.08%
Fubotv (FUBO)	2019-2022	23,735.62%
Applied Digital (APLD)	2019-2022	16,476.58%
FitLife Brands, Inc Common Stock (FTLF)	2019-2022	15,850%
INVO Fertility (IVF)	2019-2022	14,663.34%
Weatherford International (WFRD)	2019-2022	9,491.02%
Castellum (CTM)	2019-2022	8,773.24%
Enphase Energy (ENPH)	2019-2022	5,622.68%
374Water Inc Common Stock (SCWO)	2019-2022	5,620%
Cassava Sciences (SAVA)	2019-2022	3,375.29%
Teekay Tankers (TNK)	2019-2022	3,168.33%
Celsius (CELH)	2019-2022	2,969.03%
Bone Biologics (BBLG)	2019-2022	2,924%
Axsome Therapeutics (AXSM)	2019-2022	2,644.84%
Centrus Energy (LEU)	2019-2022	1,880.49%
Sigma Lithium Resources (SGML)	2019-2022	1,718.3%
Empire Petroleum (EP)	2019-2022	1,608.33%